Article Listing - US PRODUCT NEWS IN BRIEF

NEG LIST TALKS CONTINUE IN SPAIN

27 April 1992

Talks are continuing between the Spanish Health Ministry and the Spanish pharmaceutical industry association, Farmaindustria, on the selective financing of...

BTG'S rhGH APPROVED IN FRANCE

27 April 1992

US biotechnology company Bio-Technology General Corp has received approval to market Eskatrope, its recombinant version of human growth hormone which...

UPJOHN'S GLYNASE APPROVED IN USA

27 April 1992

Upjohn has received marketing approval from the US Food and Drug Administration for an improved formulation of its leading antidiabetic...

IVAX CORP ACQUIRES WAVERLEY PHARMA

27 April 1992

US-based Ivax Corporation has acquired the British company Waverley Pharmaceutical for around L 22 million ($38.5 million) in stock. The...

IMMUNOMEDICS PRESIDENT RESIGNS

27 April 1992

Russell McLauchlan has resigned as president of Immuno-medics. According to the company, a successor is expected to be announced by...

BELMAC EUROPE LAUNCHES EPO PRODS

27 April 1992

Belmac Europe has launched three oral powder formulations of erythromycin, under the trade name Biolid, onto the French market. The...

EUROCETUS TO MARKET PROLEUKIN

27 April 1992

US pharmaceutical company Chiron's Dutch subsidiary, EuroCetus BV, has received approval from the Austrian Board of Health to market Proleukin...

"STRINGS" WITH US ACCELERATED APPRO

27 April 1992

The accelerated approval proposal which the US Food and Drug Administration published this month changes the set of principles which...

Japan FTC To Reduce Antitrust Exemptions

27 April 1992

Moves to reduce exemptions from the Antimonopoly Law, by halving the number of products eligible for a system that allows...

INST FARMA SERONO POSTS LOWER PROFITS

27 April 1992

Instituto Farmacologico Serono, which is listed on the Rome bourse, ended 1991 with 6.7 million lire ($5.4 million) profit, down...

Showing 94331-94340 of 95558 articles